上海交通大学学报（医学版）

上海交通大学学报（医学版） >

2026 , Vol. 46 >Issue 5: 594 - 601

DOI: https://doi.org/10.3969/j.issn.1674-8115.2026.05.005

论著 · 基础研究

香草乙酮对牙周炎小鼠认知损害的保护作用

  • 李腾 ,
  • 徐丽娜 ,
  • 江旖婷 ,
  • 何智妍 ,
  • 宋忠臣 ,
  • 周薇
展开
  • 1.上海交通大学医学院附属第九人民医院牙周病科，上海交通大学口腔医学院，国家口腔医学中心，口腔疾病国家临床医学研究中心，上海市口腔医学重点实验室，上海市口腔医学研究所，上海 200011
    2.上海交通大学医学院附属第九人民医院口腔微生态与系统性疾病实验室，上海交通大学口腔医学院，国家口腔医学中心，口腔疾病国家临床医学研究中心，上海市口腔医学重点实验室，上海市口腔医学研究所，上海 200125
周　薇，研究员，博士；电子信箱：sweetzw@hotmail.com。

收稿日期: 2025-11-17

  录用日期: 2026-01-08

  网络出版日期: 2026-05-28

基金资助

国家自然科学基金(82270974);上海交通大学医学院附属第九人民医院交叉基金(JYJC202308)

收起

Protective effect of apocynin on periodontitis-induced cognitive impairment in mice

  • Li Teng ,
  • Xu Lina ,
  • Jiang Yiting ,
  • He Zhiyan ,
  • Song Zhongchen ,
  • Zhou Wei
Expand
  • 1.Department of Periodontology, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology, Shanghai 200011, China
    2.Laboratory of Oral Microbiota and Systemic Diseases, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine; College of Stomatology, Shanghai Jiao Tong University; National Center for Stomatology; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology; Shanghai Research Institute of Stomatology, Shanghai 200125, China
Zhou Wei, E-mail: sweetzw@hotmail.com.

Received date: 2025-11-17

  Accepted date: 2026-01-08

  Online published: 2026-05-28

Supported by

National Natural Science Foundation of China(82270974);Cross Disciplinary Research Fund of Shanghai Ninth People′s Hospital, Shanghai Jiao Tong University School of Medicine(JYJC202308)

Fold

摘要

目的·探究香草乙酮（apocynin，APO）对牙周炎小鼠认知损害的作用及其机制。方法·选取C57BL/6小鼠，通过龈沟注射牙龈卟啉单胞菌来源脂多糖（Porphyromonas gingivalis lipopolysaccharide，P.g LPS）建立牙周炎模型，并采用腹腔注射香草乙酮对其进行干预。借助显微计算机断层成像（micro computed tomograph，Micro-CT）观察牙槽骨吸收情况；运用旷场实验与莫里斯水迷宫评估小鼠认知功能；采用伊文思蓝染色法检测血脑屏障（blood-brain barrier，BBB）通透性；通过实时荧光定量PCR检测脑组织中紧密连接蛋白闭锁小带蛋白1（zonula occludens-1，Zo-1）、闭合蛋白（occludin，Ocln）以及炎症因子白细胞介素-1β（interleukin-1β，Il-1β）、白细胞介素-8（interleukin-8，Il-8）的mRNA表达水平。结果·与P.g LPS组相比，P.g LPS+APO组小鼠骨体积分数（bone volume/total volume，BV/TV）与骨密度（bone mineral density，BMD）显著提升（P=0.037，P=0.038），骨表面积与骨体积之比（bone surface/bone volume，BS/BV）明显降低（P=0.017）。旷场实验表明，各组活动能力无显著差异。莫里斯水迷宫实验中，在定位航行阶段，自第3日起，P.g LPS+APO组小鼠的潜伏期显著短于P.g LPS组（P<0.001）；在空间探索阶段中，P.g LPS+APO组穿越平台次数明显多于P.g LPS组（P=0.006）。伊文思蓝染色结果显示，P.g LPS+APO组脑组织的吸收度值较P.g LPS组显著降低（P<0.001）。与P.g LPS组相比，P.g LPS+APO组小鼠脑组织中紧密连接蛋白Zo-1（P=0.024）和Ocln（P=0.014）的mRNA表达上调，炎症因子Il-1β和Il-8的mRNA表达下调（P=0.001，P=0.002）。结论·香草乙酮可通过抑制P.g LPS诱导的炎症反应，减轻牙槽骨吸收，降低血脑屏障通透性，进而缓解牙周炎相关认知损害，提示其具有潜在的神经保护作用。

关键词： 香草乙酮; 牙周炎; 认知损害; 血脑屏障

本文引用格式

李腾 , 徐丽娜 , 江旖婷 , 何智妍 , 宋忠臣 , 周薇 . 香草乙酮对牙周炎小鼠认知损害的保护作用[J]. 上海交通大学学报（医学版）, 2026 , 46(5) : 594 -601 . DOI: 10.3969/j.issn.1674-8115.2026.05.005

Abstract

Objective ·To investigate the effect of apocynin (APO) on periodontitis-induced cognitive impairment in mice and its underlying mechanism. Methods ·C57BL/6 mice were used. A periodontitis model was established by injecting Porphyromonas gingivalis lipopolysaccharide (P.g LPS) into the palatal gingival sulcus of the maxillary first molars twice a week for four weeks. Apocynin was administered intraperitoneally as an intervention. Micro-computed tomography (Micro-CT) was used to observe alveolar bone resorption. The open field test and the Morris water maze were employed to assess cognitive function. Evans blue staining was used to detect blood-brain barrier permeability. Real-time qPCR was used to detect the mRNA expression levels of tight junction proteins zonula occludens-1 (Zo-1) and occludin (Occl), as well as interleukin-1β (Il-1β) and interleukin-8 (Il-8) in brains. Results ·Compared with the P.g LPS group, mice in the P.g LPS plus apocynin group showed significantly increased bone volume fraction (BV/TV) and bone mineral density (BMD), and a significantly decreased bone surface/bone volume ratio (BS/BV). In the open field test, there were no significant differences in locomotor activity among the four groups. In the Morris water maze, the latency of the P.g LPS plus apocynin group was significantly shorter than that of the P.g LPS group from day 3 during the navigation phase. In the probe test, the P.g LPS plus apocynin group crossed the target platform significantly more times than the P.g LPS group. Evans blue staining indicated that the absorbance values decreased significantly in the P.g LPS plus apocynin group. Compared with the P.g LPS group, the expression of Zo-1 (P=0.024) and Ocln (P=0.014) was upregulated, while Il-1β (P=0.001) and Il-8 (P=0.002) were downregulated in the brains of mice treated with apocynin. Conclusion ·Apocynin can alleviate periodontitis-induced cognitive impairment by inhibiting P.g LPS-induced inflammation, reducing alveolar bone resorption, and decreasing blood-brain barrier permeability. These findings suggest that apocynin may have potential neuroprotective effects, which provides an experimental basis for the treatment of periodontitis-related cognitive impairment.

Key words： apocynin; periodontitis; cognitive impairment; blood-brain barrier

参考文献

[1] Slots J. Periodontitis: facts, fallacies and the future[J]. Periodontol 2000, 2017, 75(1): 7-23.
[2] Hajishengallis G. Interconnection of periodontal disease and comorbidities: evidence, mechanisms, and implications[J]. Periodontol 2000, 2022, 89(1): 9-18.
[3] Villar A, Paladini S, Cossatis J. Periodontal disease and Alzheimer′s: insights from a systematic literature network analysis[J]. J Prev Alzheimers Dis, 2024, 11(4): 1148-1165.
[4] Scheltens P, de Strooper B, Kivipelto M, et al. Alzheimer′s disease[J]. Lancet, 2021, 397(10284): 1577-1590.
[5] Tolosa E, Garrido A, Scholz S W, et al. Challenges in the diagnosis of Parkinson′s disease[J]. Lancet Neurol, 2021, 20(5): 385-397.
[6] Liccardo D, Marzano F, Carraturo F, et al. Potential bidirectional relationship between periodontitis and Alzheimer′s disease[J]. Front Physiol, 2020, 11: 683.
[7] Kanimozhi, Aishwarya K, Yadav S, et al. Exploring the link between periodontal disease and systemic conditions: implications for Alzheimer′s, Parkinson′s, and rheumatoid arthritis[J]. J Pharm Bioallied Sci, 2024, 16(Suppl 4): S3775-S3777.
[8] Li R H, Wang J N, Xiong W, et al. The oral-brain axis: can periodontal pathogens trigger the onset and progression of Alzheimer′s disease?[J]. Front Microbiol, 2024, 15: 1358179.
[9] de Diego-Otero Y, El Bekay R, García-Guirado F, et al. Apocynin, a selective NADPH oxidase (Nox2) inhibitor, ameliorates behavioural and learning deficits in the fragile X syndrome mouse model[J]. Biomedicines, 2024, 12(12): 2887.
[10] Hou L Y, Sun F Q, Huang R X, et al. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson′s disease model[J]. Redox Biol, 2019, 22: 101134.
[11] Joseph E, Villalobos-Acosta D M á, Torres-Ramos M A, et al. Neuroprotective effects of apocynin and galantamine during the chronic administration of scopolamine in an Alzheimer′s disease model[J]. J Mol Neurosci, 2020, 70(2): 180-193.
[12] Jungbauer G, St?hli A, Zhu X L, et al. Periodontal microorganisms and Alzheimer disease: a causative relationship?[J]. Periodontol 2000, 2022, 89(1): 59-82.
[13] Cichońska D, Mazu? M, Kusiak A. Recent aspects of periodontitis and Alzheimer′s disease: a narrative review[J]. Int J Mol Sci, 2024, 25(5): 2612.
[14] Lei S, Li J, Yu J J, et al. Porphyromonas gingivalis bacteremia increases the permeability of the blood-brain barrier via the Mfsd2a/Caveolin-1 mediated transcytosis pathway[J]. Int J Oral Sci, 2023, 15(1): 3.
[15] Qian X S, Lin X X, Hu W Q, et al. Intestinal homeostasis disrupted by periodontitis exacerbates Alzheimer′s Disease in APP/PS1 mice[J]. J Neuroinflammation, 2024, 21(1): 263.
[16] Shen H, Jiang Y T, Qiu C, et al. Abnormal amyloid precursor protein processing in periodontal tissue in a murine model of periodontitis induced by Porphyromonas gingivalis[J]. J Periodontal Res, 2024, 59(2): 395-407.
[17] Jiang M Z, Zhang X W, Yan X, et al. GSK3β is involved in promoting Alzheimer′s disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F/NL-F knock-in mice[J]. Brain Behav Immun, 2021, 98: 1-12.
[18] Zhang X, Zhang X, Qiu C, et al. The imbalance of Th17/Treg via STAT3 activation modulates cognitive impairment in P. gingivalis LPS-induced periodontitis mice[J]. J Leukoc Biol, 2021, 110(3): 511-524.
[19] Qiu C, Yuan Z, He Z Y, et al. Lipopolysaccharide preparation derived from Porphyromonas gingivalis induces a weaker immuno-inflammatory response in BV-2 microglial cells than Escherichia coli by differentially activating TLR2/4-mediated NF-κB/STAT3 signaling pathways[J]. Front Cell Infect Microbiol, 2021, 11: 606986.
[20] Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities[J]. Nat Rev Immunol, 2021, 21(7): 426-440.
[21] Huang X W, Hussain B, Chang J L. Peripheral inflammation and blood-brain barrier disruption: effects and mechanisms[J]. CNS Neurosci Ther, 2021, 27(1): 36-47.
[22] Sweeney M D, Zhao Z, Montagne A, et al. Blood-brain barrier: from physiology to disease and back[J]. Physiol Rev, 2019, 99(1): 21-78.
[23] Zlokovic B V. The blood-brain barrier in health and chronic neurodegenerative disorders[J]. Neuron, 2008, 57(2): 178-201.
Options
文章导航

/

〈 〉